Drug
Arv 806
Arv 806: highest development phase Phase 1/2, developed by Arvinas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arvinas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARV-806 NCT07023731 | Phase 1/2 | KRAS G12D Mutation |
Latest
No recent events.
Follow Arv 806 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.